Navigation Links
Cordex Completes Production of ATPace(TM) Clinical Trial Material
Date:6/29/2009

LA JOLLA, Calif., June 29 /PRNewswire-FirstCall/ -- Cordex Pharma, Inc. (OTC Bulletin Board: CDXP) announced today that it has successfully completed the production of the ATPace(TM) clinical trial material (CTM) in preparation for planned pivotal clinical trials. The protocol of these clinical trials has been approved by the U.S. Food and Drug Administration (FDA) under the Special Protocol Assessment process.

ATPace(TM) is a novel, proprietary, stable, injectable formulation of adenosine 5'-triphosphate (ATP) under development as a therapeutic and diagnostic drug for the management of cardiac arrhythmias. A stable liquid formulation of ATP is a prerequisite for ATPace(TM)'s clinical superiority over adenosine, the only approved competition in the U.S. The maintenance of intact ATP molecules in solution is critical for the unique bradycardic effects of ATP, in particular its blockade of atrio-ventricular nodal conduction. Cordex has filed a formulation patent covering this stable liquid formulation of ATP for intravenous administration.

The ATPace(TM) CTM was produced off-site by a U.S. manufacturer of sterile injectable products under the regulatory supervision of Cordex and Cato Research, Inc. The CTM will be used in the planned clinical trials for the acute treatment of patients presenting with paroxysmal supraventricular tachycardia (PSVT) in the emergency room.

Several formulations of ATP have been used in Europe for over five decades as the drug of choice for the acute conversion of PSVT to normal sinus rhythm. During this extended period of use, ATP manifested an excellent safety and efficacy profile. Cordex intends to use clinical data obtained in Europe as a part of the ATPace(TM)'s NDA under section 505b(2).

"We are pleased to reach this important milestone in the development program of ATPace(TM)," said Amir Pelleg, Ph.D., Cordex's President and CSO. "Together with Cato Research,
'/>"/>

SOURCE Cordex Pharma, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Cordex Pharma Forms Heart Failure Medical Advisory Board
2. Cordex Pharma Presents New Frontiers in Cardiovascular Medicines on January 29
3. OncoGenex Pharmaceuticals Completes Amendment to Phase 3 Special Protocol Assessment for Confirming Survival Benefit in Patients Receiving OGX-011 with First-Line Docetaxel for Metastatic Prostate Cancer
4. Brooks Instrument Completes Acquisition of Celerity's Instrumentation Division
5. Sinovac Completes Construction of H1N1 Virus Seed Bank
6. Medivation Completes Enrollment in Confirmatory, Pivotal Phase 3 CONNECTION Trial of Dimebon in Patients With Alzheimers Disease
7. Proteon Therapeutics Completes Second Closing of Equity Financing; Raises Total Series B to $50 million
8. Charleston Laboratories, Inc. Completes Exploratory Bioequivalence Study of CL-108
9. Clarient Completes Second Tranche of Private Placement of Convertible Preferred Stock With Oak Investment Partners
10. Oncolytics(R) Biotech Inc. Completes Patient Enrolment in U.S. Phase 2 Sarcoma Study
11. NovImmune Completes CHF 62.5 (USD 54.8) Million Equity Financing to Move Portfolio Forward and Reacquire Product Rights to Lead Antibodies

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...v. 25 Ardea Biosciences,...D. Quart, Pharm.D., president and chief executive ...nual Health Care Conference. , ,Presentation deta...lth Care Conference,Date: Tuesday, December 1... The New York Palace Hotel, New York, NY,Webcast:...
(Date:11/24/2009)...Ambassador to also Visit Detroit , ...avid Appia, French Ambassador for International In...ance Agency, , , , ,What: Ambassador Appia is ava...siness initiatives adopted by France to further de... for innovation and development., , ,When: Availab...
(Date:11/24/2009)...ENHEIM, Ontario, Nov. 24 ...uiring the assets of Hyland Seeds, a division of T...n of Hyland Seeds will further expand Dow AgroScie...pates the introduction of SmartStax(TM) in 201...Technology in corn in 2012. The transactional clos...
(Date:11/24/2009)... Health care employment grew by 29,000 jobs in Oc...consistent growth during the U.S. recession. Howev...ble, and health systems are coming closer to havin...st administrators. , (Voc...ntinued growing in October despite the shedding of...
Breaking Biology Technology:Ardea Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 4
...nies tend to have a good grasp on their tangible p...understand the value of their products. On the oth...intellectual property. Companies may understand th...hem, and may even understand that it is possible t...en companies lack a complete understanding of the ...
...ON NameProtect Inc. has announced the availabil...ned to deliver intellectual property data to trade... sources within an online environment. Announced F...d competitive trademark clearance and protection s... will be able to integrate references from both tr...
...onsin,s Case for Combining Efficiency and Renewabl...is finally being recognized as an important compon...es like Pennsylvania have begun discussion about i...all renewable portfolios and Renewable Portfolio ...ing Energy Efficiency and Renewable will allow the...
Other Biology Technology:Save money through smart patenting 2Save money through smart patenting 3Save money through smart patenting 4NameProtect announces Web-enhanced trademark software 2Energy efficiency is no longer the Rodney Dangerfield of energy 2Energy efficiency is no longer the Rodney Dangerfield of energy 3
(Date:11/24/2009)... of ring-shaped protein motors has been uncovered ... Laboratory (Berkeley Lab) using a state-of-the-ar... Light Source (ALS). These protein motors play piv... are vital to the survival of all biological cells...papillomavirus, which has been linked to cervical ...
(Date:11/24/2009)...-- The Wildlife Conservation Society (WCS) announc...g population of Siberian tigers has likely decline... and habitat loss. , WCS says the re...eds to be done to protect remaining populations of...ort was released by the Siberian Tiger Monitoring ...
(Date:11/24/2009)...bate. A high-profile study a few years ago suggest... from trees and leaves, evidence for a very close ...s. , But new research from the University of Was... provide a much richer diet for fish and other aqu...ek in the Proceedings of the National Academy of ...
Breaking Biology News(10 mins):Atomic-level snapshot catches protein motor in action 2Atomic-level snapshot catches protein motor in action 3Atomic-level snapshot catches protein motor in action 4Report shows dramatic decline in Siberian tigers 2Fish food fight: Fish don't eat trees after all, says new study 2Fish food fight: Fish don't eat trees after all, says new study 3Fruitfly Model of a Neuropathic Disease Demonstrates Novel Role for Proteins in the Family of aTyr Pharmas Product Class 4717 1Fruitfly Model of a Neuropathic Disease Demonstrates Novel Role for Proteins in the Family of aTyr Pharmas Product Class 4717 2Fruitfly Model of a Neuropathic Disease Demonstrates Novel Role for Proteins in the Family of aTyr Pharmas Product Class 4717 3Sirius Genomics Announces New Collaboration with Assistance Publique Hopitaux de Paris 4716 1Sirius Genomics Announces New Collaboration with Assistance Publique Hopitaux de Paris 4716 2Top Newport Beach Based Plastic Surgery Practice Triples Its Revenue 3B Celebrates Two Year Anniversary 51421 1Top Newport Beach Based Plastic Surgery Practice Triples Its Revenue 3B Celebrates Two Year Anniversary 51421 2
...ancer cells and nervous system neurons may not loo...ys to survive, according to new research from the ... of Medicine. , The study published in the Decemb...describe how neurons (nerve cells) and cancer cell... of biochemical events called apoptosis that event...
...ve created a new family of fluorescent probes call...asure the presence of reactive oxygen species. Rea...es of oxygen that have been implicated in a variet...therosclerosis. , "We,ve shown that the hydrocyan... oxygen species, superoxide and the hydroxide radi...
... adapt to a warming Arctica frozen seascape that c...an unlikely source: snow goose eggs. New calculati...akup and of snow goose nesting near the western Hu...ith an alternative source of food. This new analys...six subadult male bears were seen among snow goose...
Other Biology News:Shared survival mechanism explains why 'good' nerve cells last and 'bad' cancer cells flourish 2Researchers create new class of fluorescent dyes to detect reactive oxygen species in vivo 2Researchers create new class of fluorescent dyes to detect reactive oxygen species in vivo 3Goose eggs may help polar bears weather climate change 2
... The GenElute Gel Extraction Kit combines silica- ...or vacuum column format. DNA fragments of interest...lubilizing the gel. The Gel Solubilization Solutio...in either TBE or TAE buffer. Extracted DNA fragmen...
... The FastPlax Titer Kit is designed for determinat...ad of 46 days as in other methods. Classical deter...pearance of plaques, but the FastPlax Kit takes ad...AcNPV gp64 glycoprotein on the cell surface as ear...
iQ Imaging Software from Andor Technology
... The GenElute™ Minus EtBr Spin Columns provi...um bromide (EtBr)-free DNA (100 bp to 10 kb) from.... The DNA band is excised from an agarose gel and ...ase of the column are a series of membranes and fi...
Biology Products: